The Quantellect read.As of Nov 19, 2026, 5 active firms cover Xpeng Inc: 3 rate it Buy or better, 1 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets range widely, $11.50 to $25.00 (about 2.2x), a sign of real disagreement on valuation. The average target of $17.38 sits 78% above the current $9.74. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.70 next quarter toward $-1.30 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Neutral
Strong Buy00%
Buy360%
Neutral120%
Sell120%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$17.38
+78.4% upside
Average target across 4 active firms as of Nov 19, 2026 vs $9.74 current
Highest Target$25.00
Average Target$17.38
Lowest Target$11.50
Detailed analyst forecasts for XPEV
Showing 1–4 of 4 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 3 of 5 active firms rate XPEV a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
XPEV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.70
Range $-0.73 – $-0.67 · 2 analysts · -60% YoY
Next period, 2 analysts expect Xpeng Inc to earn $-0.70 a share (range $-0.73 – $-0.67), versus $-1.76 a year earlier. Full-year consensus is $-4.18, growing to $-1.30 the year after.
REVENUE · NEXT QUARTER
$23.0B
Range $16.3B – $27.5B · 2 analysts · +76% YoY
Revenue is expected to reach $23.0B (range $16.3B – $27.5B), +76.2% year-over-year. Full-year consensus is $88.4B, rising to $110.1B next year.
Top analysts covering Xpeng Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XPEV.
#1
Jiong Shao
Barclays · Rank #302
Sell
$14.00+43.7% to target
Overall win rate
42%
+ Follow
#2
EH
Eugene Hsiao
Macquarie
Buy
$19.00+95.1% to target
Coverage
—
+ Follow
#3
NL
Nick Lai
JP Morgan
Neutral
$11.50+18.1% to target
Coverage
—
+ Follow
#4
JC
Jeff Chung
Citigroup
Buy
$21.40+119.7% to target
Coverage
—
+ Follow
#5
MH
Ming Hsun Lee
B of A Securities
Buy
$18.00+84.8% to target
Coverage
—
+ Follow
XPEV stock forecast FAQ
What is XPEV's average 12-month price target?+
The 4 active firms with a live target average $17.38 for Xpeng Inc over the next 12 months, ranging from a $25.00 high to a $11.50 low, as of Nov 19, 2026.
Is XPEV stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 5 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 1 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for XPEV?+
The Street-high target is $25.00 (Freedom Capital Markets), and the Street-low is $11.50 (JP Morgan). The average of all 4 active-firm targets is $17.38.
How many active Wall Street firms cover XPEV?+
5 active firms have a recognized rating on Xpeng Inc as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering XPEV?+
Among analysts who currently cover XPEV, Jiong Shao of Barclays has the strongest overall Quantellect track record (Rank #302). Their current call is Sell with a $14.00 target.
What is Xpeng Inc's projected EPS for next quarter?+
The consensus estimate is $-0.70 per share (range $-0.73 – $-0.67) across 2 analysts. Full-year EPS is projected at $-4.18, rising to $-1.30 the following year.
How much revenue is Xpeng Inc expected to report next quarter?+
Consensus revenue is $23.0B (range $16.3B – $27.5B). Full-year revenue is projected at $88.4B, growing to $110.1B next year.
Have analysts been upgrading or downgrading XPEV lately?+
As of Nov 19, 2026, 3 of 5 active firms rate XPEV a Buy (1 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XPEV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.